title: Phase II study of pirarubicin in advanced non-small cell lung cancer.
authors.affiliation: Département de Médecine, Institut Gustave-Roussy, Villejuif, France.
authors.forename: P
authors.initials: P
authors.lastname: Berthaud
authors.forename: T
authors.initials: T
authors.lastname: Le Chevalier
authors.forename: J
authors.initials: J
authors.lastname: Berille
authors.forename: P
authors.initials: P
authors.lastname: Herait
authors.forename: P
authors.initials: P
authors.lastname: Baldeyrou
authors.forename: T
authors.initials: T
authors.lastname: Tursz
authors.forename: R
authors.initials: R
authors.lastname: Arriagada
authors.forename: M
authors.initials: M
authors.lastname: Spielmann
authors.forename: M
authors.initials: M
authors.lastname: Hayat
mesh_terms: D000328:Adult; D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004317:Doxorubicin / Q000031:analogs & derivatives; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D004317:Doxorubicin; C027260:pirarubicin